- In late June 2026, Arlo Technologies reported that Aloe Care Health’s new ConnectAI wellness calling solution will be integrated into Home Helpers Home Care’s Direct Link powered by Aloe Care suite, deepening their existing AI-enabled in-home care collaboration.
- This move highlights how Arlo’s expanding connected care portfolio is being used in real-world aging-in-place programs to deliver proactive wellness check-ins, medication reminders, and earlier issue detection for clients and care teams.
- Next, we’ll examine how the ConnectAI rollout across Home Helpers’ in-home care network could influence Arlo’s subscription-led investment narrative.
We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
Arlo Technologies Investment Narrative Recap
To own Arlo, you need to believe its shift to higher margin subscriptions, powered by differentiated AI services, can offset pressure on commoditized hardware. The Aloe Care ConnectAI rollout fits that story by showing Arlo’s technology being used in real care settings, but it does not materially change the near term focus on scaling subscriptions or the key risk that price competition and lower hardware margins could still weigh on profitability.
Among recent announcements, the Samsung SmartThings partnership in early 2026 is especially relevant here, as it similarly extends Arlo’s AI security platform into a broader installed base through a large distribution partner. Together with the Aloe Care and Home Helpers collaboration, it reinforces the core catalyst of expanding Arlo’s ecosystem reach, which is important as the company tries to grow recurring subscription revenue while managing hardware margin pressure.
However, against this positive adoption story, investors should also understand how intensifying smart home competition could...
Read the full narrative on Arlo Technologies (it's free!)
Arlo Technologies' narrative projects $643.1 million revenue and $50.3 million earnings by 2029. This requires 4.7% yearly revenue growth and about a $19.7 million earnings increase from $30.6 million today.
Uncover how Arlo Technologies' forecasts yield a $21.40 fair value, a 65% upside to its current price.
Exploring Other Perspectives
Three fair value estimates from the Simply Wall St Community range from US$17.12 to US$21.40, highlighting how far opinions can spread. You should weigh those views against the risk that increasing hardware commoditization and lower average selling prices could pressure margins and test Arlo’s subscription led thesis over time.
Explore 3 other fair value estimates on Arlo Technologies - why the stock might be worth as much as 65% more than the current price!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Arlo Technologies research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Arlo Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arlo Technologies' overall financial health at a glance.
Looking For Alternative Opportunities?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
- The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com